Form 4: Vaxart CFO Phillip E. Lee Reports Acquisition of Shares and Stock Options

Phillip E. Lee, CFO of Vaxart, Inc., reports the acquisition of 406,000 shares of common stock and 610,000 stock options on March 24, 2025.

Summary

• On March 24, 2025, Phillip E. Lee, the Chief Financial Officer of Vaxart, Inc., acquired 406,000 shares of common stock.
• These shares were obtained through the vesting of restricted stock units.
• Lee also acquired 610,000 stock options with an exercise price of $0.5126.
• The stock options vest over time, starting with 25% on March 24, 2026, and the remainder in 36 equal monthly installments, fully vesting on March 24, 2029.
• Following these transactions, Lee directly owns 631,619 shares of Vaxart common stock and 610,000 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CFO increasing their stake in the company is generally a good sign, but it's a routine transaction related to compensation.

Positives

• The CFO's acquisition of shares and stock options could be interpreted as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units and stock options suggests a long-term commitment by the CFO to the company's success.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. This filing is a routine disclosure required by the SEC.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the biotechnology industry, used to align management's interests with those of shareholders.
• The vesting schedules described are fairly standard, with vesting occurring over a period of several years to incentivize long-term performance.
• Comparable companies like Moderna or BioNTech also utilize stock options and restricted stock units as part of their executive compensation packages.

Stakeholder Impact

• Shareholders may view the CFO's increased ownership as a positive signal.
• Employees may see this as a sign of stability and confidence in the company's leadership.

Key Dates

Keywords

Vaxart, VXRT, Phillip E. Lee, CFO, stock options, common stock, Form 4, insider trading, restricted stock units, beneficial ownership